We demonstrate a simple templateless and surfactant-free wet-chemical method of preparing silver (Ag) nanostructures with different dendritic morphologies at room temperature. This has been accomplished by aging the aqueous mixture of AgNO3 and citrate salts, carrying different cations for different time periods. Transmission electron microscopic (TEM) and X-ray diffraction (XRD) studies confirmed the formation of single-crystalline dendritic Ag nanostructures. It has been found that the nature and the concentration of citrate salt have a significant effect on the morphology of the formed Ag nanostructures. A possible formation mechanism has also been discussed on the basis of monitoring the surface plasmon resonance properties and TEM images with time during the course of formation of silver dendrites. The formed dendritic silver nanostructures showed excellent catalytic activity in the borohydride reduction of p-nitrophenol to p-aminophenol compared to the spherical silver nanoparticles.

Synthetic oligopeptides with a tryptophan residue at the C-terminus have been used for the synthesis of gold and silver nanoparticles at pH 11. The tryptophan residue in the peptides is responsible for the reduction of metal ions to the respective metals, possibly through electron transfer. A mechanistic pathway has been proposed to explain the reductive properties of the tryptophan moiety of the peptide based on some spectroscopic techniques, such as UV-visible and fluorescence spectroscopy. This study reveals that some of the peptide molecules are converted to its corresponding ditryptophan, kynurenine form and some cross-linked products, all of which are highly fluorescent species. The resultant peptide-functionalized metal nanoparticles have also been characterized by UV-visible spectroscopy, transmission electron microscopy, and Fourier transform IR spectroscopy and thermogravimatric analysis.

Synthetic oligopeptides containing redox-active tyrosine residues have been employed to prepare gold and silver nanoparticles. In this reduction process an electron from the tyrosinate ion of the peptide is transferred to the metal ion at basic pH through the formation of a tyrosyl radical, which is eventually converted to its dityrosine form during the reaction. This reaction mechanism was confirmed from UV-visible, fluorescence, and EPR spectroscopy and was found to be pH-dependent. Transmission electron microscopy measurement shows that the average size and the monodispersity of gold nanoparticles increase as the number of tyrosine residues in the peptide increases. The kinetic study, based on spectrophotometric measurements of the surface plasmon resonance optical property, shows that the rate of formation of gold nanoparticles was much faster at higher pH than at lower pH and was also dependent on the number of tyrosine residues present in the peptide. The dityrosine form of the peptide was found to retain reducing properties like those of tyrosine in basic medium.

Intense research has led to a more comprehensive understanding of cancer at the genetic, molecular, and cellular levels providing an avenue for methods of increasing antitumor efficacy of drugs while reducing systemic side effects. Nanoparticulate technology is of particular use in developing a new generation of more effective cancer therapies capable of overcoming the many biological, biophysical, and biomedical barriers that the body stages against a standard intervention. Nanoparticles show much promise in cancer therapy by selectively gaining access to tumor due to their small size and modifiability. Typically, though not exclusively, nanoparticles are defined as submicroscopic particles between 1 and 100 nm. Nanoparticles are formulated out of a variety of substances and engineered to carry an array of substances in a controlled and targeted manner. Nanoparticles are prepared to take advantage of fundamental cancer morphology and modes of development such as rapid proliferation of cells, antigen expression, and leaky tumor vasculature. In cancer treatment and detection nanoparticles serve many targeted functions in chemotherapy, radiotherapy, immunotherapy, immunodetection, thermotherapy, imaging, photodynamic therapy, and anti-angiogenesis. Not only are modifying agents allowing for greater and more accurate tumor targeting, they are also aiding in the crossing of biophysical barriers such as the blood brain barrier there by reducing peripheral effects and increasing the relative amount of drug reaching in the brain. Moreover, multifunctional nanoparticles perform many of these tasks simultaneously such as targeted delivery of a potent anticancer drug at the same time as an imaging material to visualize the effectiveness of the drug utilized for treatment follow-up. In this review, several recent US and World patents developing and modifying nanoparticles for the detection, analysis, and treatment of cancer are discussed.

A simple solution-based method to prepare mainly flowerlike zinc oxide (ZnO) nanostructures using the ascorbate ion as a shape-directing/capping agent at relatively low temperature (ca. 30 and 60 degrees C) was described. However, we observed that different shapes of hierarchical ZnO nanostructures such as flowerlike, spindlelike, and spherical could be obtained with an increase in the synthesis temperature from 60 to 90 degrees C. The effects of other organic capping agents on the shape of hierarchical ZnO nanostructures were also studied. FTIR, FESEM, and XRD characterization were performed on the formed ZnO nanostructures to understand the role of ascorbate in the growth of flowerlike morphology. The nucleation and growth process can regulate by changing the metal precursor and ascorbate ion concentrations. We were able to identify intermediate nanostructures such as spherical/quasi-spherical and spindle that are very much on the pathway of formation of large, flowerlike ZnO nanostructures. Electron microscopy results indicated that these spherical/quasi-spherical ZnO nanoparticles might aggregate through oriented attachment to produce spindlelike and flowerlike nanostructures. On the basis of these results, a possible growth mechanism for the formation of flowerlike ZnO nanostructures was described. The optical properties of these differently shaped ZnO nanostructures were also described. The catalytic activities of the as-synthesized spherical and flowerlike ZnO nanostructures were tested in the Friedel-Crafts acylation reaction of anthracene with benzoyl chloride. The catalysis results indicated that the catalytic activity of flowerlike ZnO nanostructures is slightly higher than the spherical counterpart.

A novel gold nanoparticle-tripeptide (GNP-tripeptide) conjugate was prepared by peptide in-situ redox technique at ambient temperatureusing a newly designed tripeptide. This new tripeptide was nso designed that it has a C-terminus tyrosine residue, which reduced Au+3 to Au, and the terminally located free amino group was bound to the gold nanoparticle (GNP) surface resulting in highly stable Au colloids. The average diameter of the tripeptide-stabilized GNP is 8.7 +/- 2.3 nm. Tripeptide bound gold nanoparticles formed three-dimensional assemblies in the presence of an excess of similar or disimilar tripeptides. The aggregation of GNPs results in a red shift in the surface plasmon resonance from lambda max = 527 to 556 nm. The effect of the solvent, concentration, and nature of the tripeptides on the assembly process were investigated by TEM and UV-visible spectroscopy.

Sustained antiviral responses of chronic hepatitis C virus (HCV) infection have improved recently by the use of direct-acting antiviral agents along with interferon (IFN)-α and ribavirin. However, the emergence of drug-resistant variants is expected to be a major problem. We describe here a novel combinatorial small interfering RNA (siRNA) nanosome-based antiviral approach to clear HCV infection. Multiple siRNAs targeted to the highly conserved 5'-untranslated region (UTR) of the HCV genome were synthesized and encapsulated into lipid nanoparticles called nanosomes. We show that siRNA can be repeatedly delivered to 100% of cells in culture using nanosomes without toxicity. Six siRNAs dramatically reduced HCV replication in both the replicon and infectious cell culture model. Repeated treatments with two siRNAs were better than a single siRNA treatment in minimizing the development of an escape mutant, resulting in rapid inhibition of viral replication. Systemic administration of combinatorial siRNA-nanosomes is well tolerated in BALB/c mice without liver injury or histological toxicity. As a proof-of-principle, we showed that systemic injections of siRNA nanosomes significantly reduced HCV replication in a liver tumor-xenotransplant mouse model of HCV. Our results indicate that systemic delivery of combinatorial siRNA nanosomes can be used to minimize the development of escape mutants and inhibition of HCV infection.

An in situ reduction approach to synthesizing gold and silver nanoparticles by using a series of newly designed, redox-active amphiphiles at basic pH is described. These amphiphiles are the conjugates of a fatty acid (e.g., oleic acid, stearic acid, and lauric acid) and a redox-active amino acid (e.g., tryptophan or tyrosine). The amphiphile-coated nanoparticles are then efficiently transferred from water to different nonpolar organic media (such as benzene, toluene, xylene, cyclohexane, and hexane) simply by acid treatment. The phase-transfer process was monitored by UV/visible spectroscopy and transmission electron microscopy, and the results showed that the average particle size and size distribution remain almost unchanged after transferring to the organic media. The anchoring of the amphiphile to the nanoparticle surface was confirmed by FTIR spectroscopy and thermogravimetric analysis. A mechanism is proposed to describe the stability of colloidal Au and Ag nanoparticles formed in situ and their phase transfer to organic solvents. The presence of the amphiphile increases the thermal stability of the colloidal gold nanoparticle conjugates in organic solvents.